Aflatoxin B1-DNA adducts modify the effects of post-operative adjuvant transarterial chemoembolization improving hepatocellular carcinoma prognosis
Aim: DNA damage involves in the carcinogenesis of some cancer and may act as a target for therapeutic intervention of cancers. However, it is unclear whether aflatoxin B1 (AFB1)-DNA adducts (ADAs), an important kind of DNA damage caused by AFB1, affect the efficiency of post-operative adjuvant trans...
Saved in:
Main Authors: | Liyan Huang (Author), Qinqin Long (Author), Qunying Su (Author), Xiaoying Zhu (Author), Xidai Long (Author) |
---|---|
Format: | Book |
Published: |
Open Exploration Publishing Inc.,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcome of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
by: Hadeel A Helmi, et al.
Published: (2020) -
Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma
by: Zizhuo Wang, et al.
Published: (2024) -
Recent technical advances in conventional transarterial chemoembolization for hepatocellular carcinoma in Japan
by: Hiroki Higashihara, et al.
Published: (2021) -
Balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: History, background, and the roles
by: Toshiyuki Irie, et al.
Published: (2020) -
Cost-effectiveness analysis of drug-eluting beads and conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Guoliang Shao, et al.
Published: (2022)